Dozee baggage $8M for international growth
Dozee is looking for to enter new worldwide markets following its newest fundraising.
The Indian medical machine maker raised INR 71.5 crore ($8.3 million) from Temasek Belief’s C3H and different buyers.
“Past the [United States], we’re exploring new worldwide markets whereas broadening our product portfolio to cowl the whole continuum of care — from hospitals to transition care and residential settings,” an organization spokesperson stated in a press release shared with Mobihealth Information.
The corporate, which presents an AI-powered contactless important indicators monitoring and alert system, raised $6 million in a second Collection A funding spherical in 2023 to kickstart its growth.
JLK scores 4th Japan PMDA clearance
South Korean medical AI firm JLK has introduced new regulatory clearance for one in all its stroke AI software program merchandise.
It obtained its fourth approval from Japan’s Prescribed drugs and Medical Gadgets Company (PMDA) for its MRI FLAIR-based (Fluid-Attenuated Inversion Restoration) software program.
The answer analyses, visualises, and measures high-intensity areas in MRI-FLAIR sequence pictures, which helps in evaluating therapy choices for sufferers with acute ischemic stroke and predicting cognitive decline and dementia threat.
The corporate obtained its final PMDA approval for its non-contrast CT stroke AI software program in February.
Coreline Comfortable secures new US FDA, Korea MFDS approvals
One other medical AI firm, Coreline Comfortable, has additionally obtained new regulatory approvals in South Korea and america.
It obtained its eleventh 510(okay) certification from america Meals and Drug Administration for its upgraded flagship medical picture evaluation software program. The software program, now dubbed AVIEW 2.0options an optimised person interface and enhanced accessibility, safety, stability, and communication operate.
The corporate was additionally awarded Class 3 approval from South Korea’s Ministry of Meals and Drug Security for AVIEW LCS, its AI-based software program for predicting the malignancy of pulmonary nodules.
Well being genAI platform baggage $500,000
Singaporean startup FlocCare has not too long ago raised $500,000 in funding from DTVP, SDTA Ventures and different angel buyers.
Based in 2023, the corporate develops massive language fashions for producing personalised medical info for hospitals, healthcare professionals, and sufferers. It claims its fashions are “50 instances quicker, fact-checked, scalable and regulatory-compliant.”
In a press assertion, FlocCare stated it could use its contemporary funds to develop its genAI fashions to extra illness classes, together with cardiovascular ailments, persistent kidney illness, girls’s well being, and oncology.
It additionally plans to introduce its AI fashions within the United Arab Emirates, in addition to onboard new crew members.
